Supplemental material, sj-docx-2-msj-10.1177_13524585231225711 for Real-world data on siponimod-related lymphopenia among people with secondary progressive multiple sclerosis by Christopher GS Gilmartin, Natasha Hoyle, Afagh Garjani, Terri Dixon, Helena Jos, David Paling, Wallace Brownlee, Christopher Tench and Nikos Evangelou in Multiple Sclerosis Journal</p
Supplemental material, sj-docx-1-mso-10.1177_20552173231203816 for Tolerability of subcutaneous ofat...
Supplemental material, sj-docx-2-msj-10.1177_13524585231189673 for Assessing heterogeneity of treatm...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189673 for Assessing heterogeneity of treatm...
Supplemental material, sj-docx-3-msj-10.1177_13524585231225711 for Real-world data on siponimod-rela...
Supplemental material, sj-docx-1-msj-10.1177_13524585231225711 for Real-world data on siponimod-rela...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189677 for Enhancing diversity of clinical t...
Supplemental material, sj-docx-2-msj-10.1177_13524585231199031 for Association of MRI leptomeningeal...
Supplemental material, sj-docx-1-msj-10.1177_13524585231199031 for Association of MRI leptomeningeal...
Supplemental material, sj-docx-2-msj-10.1177_13524585231189678 for Enhancing involvement of people w...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189678 for Enhancing involvement of people w...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189671 for Improving the efficiency of clini...
Supplemental material, sj-docx-2-msj-10.1177_13524585231189671 for Improving the efficiency of clini...
Supplemental material, sj-docx-1-msj-10.1177_13524585221125382 for Recurrent disability progression ...
Supplemental material, sj-docx-1-msj-10.1177_13524585231199084 for Vaccination frequency in people n...
Supplemental material, sj-docx-1-msj-10.1177_13524585221122210 for Leptomeningeal enhancement under ...
Supplemental material, sj-docx-1-mso-10.1177_20552173231203816 for Tolerability of subcutaneous ofat...
Supplemental material, sj-docx-2-msj-10.1177_13524585231189673 for Assessing heterogeneity of treatm...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189673 for Assessing heterogeneity of treatm...
Supplemental material, sj-docx-3-msj-10.1177_13524585231225711 for Real-world data on siponimod-rela...
Supplemental material, sj-docx-1-msj-10.1177_13524585231225711 for Real-world data on siponimod-rela...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189677 for Enhancing diversity of clinical t...
Supplemental material, sj-docx-2-msj-10.1177_13524585231199031 for Association of MRI leptomeningeal...
Supplemental material, sj-docx-1-msj-10.1177_13524585231199031 for Association of MRI leptomeningeal...
Supplemental material, sj-docx-2-msj-10.1177_13524585231189678 for Enhancing involvement of people w...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189678 for Enhancing involvement of people w...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189671 for Improving the efficiency of clini...
Supplemental material, sj-docx-2-msj-10.1177_13524585231189671 for Improving the efficiency of clini...
Supplemental material, sj-docx-1-msj-10.1177_13524585221125382 for Recurrent disability progression ...
Supplemental material, sj-docx-1-msj-10.1177_13524585231199084 for Vaccination frequency in people n...
Supplemental material, sj-docx-1-msj-10.1177_13524585221122210 for Leptomeningeal enhancement under ...
Supplemental material, sj-docx-1-mso-10.1177_20552173231203816 for Tolerability of subcutaneous ofat...
Supplemental material, sj-docx-2-msj-10.1177_13524585231189673 for Assessing heterogeneity of treatm...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189673 for Assessing heterogeneity of treatm...